← Back to Analyst Consensus 
CORZ Buy
Core Scientific, Inc./tx
Current Price —
Implied Upside —
Analysts 28
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 4 reiterations from 3 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 16, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | — | 50% |
| Oct 15, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Oct 15, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Oct 14, 2026 | Cantor Fitzgerald | reiterate | Overweight → Overweight | — | 50% |
| Sep 23, 2026 | UBS | initiate | — → Buy | — | 54% |
| Sep 21, 2026 | Rothschild & Co | initiate | — → Neutral | — | 56% |
| Sep 17, 2026 | Wells Fargo | initiate | — → Overweight | — | 54% |
| Aug 3, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 55% |
| Jul 30, 2026 | Keefe, Bruyette & Woods | upgrade | Market Perform → Outperform | — | 58% |
| Jul 29, 2026 | Macquarie | maintain | Outperform → Outperform | — | 56% |
| Jul 29, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Jul 29, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jul 28, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Jul 28, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jun 25, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Jun 16, 2026 | Freedom Broker | initiate | — → Hold | — | 59% |
| May 27, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 55% |
| May 14, 2026 | Jefferies | maintain | Buy → Buy | — | 52% |
| May 13, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| May 7, 2026 | Macquarie | maintain | Outperform → Outperform | — | 56% |
| May 7, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Apr 9, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | — | 50% |
| Mar 4, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Mar 4, 2026 | Macquarie | maintain | Outperform → Outperform | — | 56% |
| Mar 3, 2026 | Ladenburg Thalmann | maintain | Buy → Buy | — | 45% |
| Mar 3, 2026 | Needham | upgrade | Hold → Buy | — | 50% |
| Mar 3, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | — | 50% |
| Mar 3, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jan 27, 2026 | Keefe, Bruyette & Woods | maintain | Outperform → Outperform | $25 | 58% |
| Jan 6, 2026 | BTIG | upgrade | Neutral → Buy | $23 | 52% |
| Dec 18, 2025 | Citizens | upgrade | Market Perform → Market Outperform | $30 | 47% |
| Nov 3, 2025 | Bernstein | maintain | Outperform → Outperform | $24 | 52% |
| Oct 31, 2025 | Macquarie | upgrade | Neutral → Outperform | $34 | 56% |
| Oct 28, 2025 | HC Wainwright & Co. | upgrade | Neutral → Buy | $25 | 44% |
| Oct 28, 2025 | Clear Street | upgrade | Hold → Buy | $23 | 48% |
| Oct 27, 2025 | HC Wainwright & Co. | upgrade | Neutral → Buy | $25 | 44% |
| Oct 24, 2025 | Cantor Fitzgerald | maintain | Overweight → Overweight | $26 | 50% |
| Oct 23, 2025 | Roth Capital | upgrade | Neutral → Buy | $23.5 | 53% |
| Sep 29, 2025 | Macquarie | maintain | Neutral → Neutral | $18 | 56% |
| Aug 22, 2025 | Roth Capital | maintain | Neutral → Neutral | $17 | 53% |
| Aug 19, 2025 | Macquarie | maintain | Neutral → Neutral | $15 | 56% |
| Aug 18, 2025 | Jefferies | maintain | Buy → Buy | $22 | 52% |
| Aug 12, 2025 | JMP Securities | reiterate | Market Perform → Market Perform | $0 | 53% |
| Aug 11, 2025 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $0 | 44% |
| Jul 14, 2025 | JMP Securities | downgrade | Market Outperform → Market Perform | $15 | 53% |
| Jul 10, 2025 | Macquarie | downgrade | Outperform → Neutral | $15 | 56% |
| Jul 10, 2025 | Needham | downgrade | Buy → Hold | $0 | 50% |
| Jul 8, 2025 | Roth Capital | downgrade | Buy → Neutral | $20 | 53% |
| Jul 8, 2025 | HC Wainwright & Co. | downgrade | Buy → Neutral | $0 | 44% |
| Jul 7, 2025 | BTIG | downgrade | Buy → Neutral | $20 | 52% |
Price Target Trend
Jul 19, 2026 Oct 26, 2026
EPS Estimates
0q —
0y —
+1y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days